CORD BLOOD ASSOCIATION

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2015–2025

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2025	—	5	1
2024	—	4	1
2023	—	4	1
2022	—	5	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
SIDLEY AUSTIN LLP	—	47

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Health Resources & Services Administration (HRSA)	36
Food & Drug Administration (FDA)	35
White House Office	18
HOUSE OF REPRESENTATIVES	15
SENATE	11

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	47
Budget/Appropriations	Budget/Appropriations	47
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	47
Aviation/Airlines/Airports	Aviation/Airlines/Airports	6

Bills Explicitly Cited (21)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · fourth_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · fourth_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · fourth_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

Show 17 more cited filings

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2016 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · fourth_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · fourth_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · fourth_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

H.R. 2820114th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2015

2015 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R.2820

Source: Senate LDA

CORD BLOOD ASSOCIATION — Lobbying Disclosure | Poliscope